Concepedia

Arlene Lum

AL

4

Publications

181

Citations

4

H-Index

2015

Active since

Affiliations

Allergan (United States)(Current)

University of California, Irvine

Arlene Lum is an author at Allergan (United States) specializing in pharmacotherapy, medicine, and clinical trials.

Top concepts

Publications per year

2015–2020

4

Publications

4

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females

Mitchell F. Brin, Suresh Durgam, Arlene Lum et al. · International Clinical Psychopharmacology · 2019 · 59 citations · Full text

, , +22

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine

Paul Winner, Marielle A. Kabbouche, Marcy Yonker et al. · Headache The Journal of Head and Face Pain · 2020 · 49 citations · Full text

Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe

Manjit Matharu, Julio Pascual, Ingela Nilsson Remahl et al. · Cephalalgia · 2017 · 48 citations · Full text

, , +9

Ministry of Health Clinical Practice Guidelines: Anxiety Disorders

Leslie Lim, HN Chan, PH Chew et al. · Singapore Medical Journal · 2015 · 25 citations · Full text

Rows per page

1–4 of 4